An ISCT Stem Cell Engineering Committee Position Statement on Immune Reconstitution: the importance of predictable and modifiable milestones of immune reconstitution to transplant outcomes-Reference-Cited by-同舟云学术

An ISCT Stem Cell Engineering Committee Position Statement on Immune Reconstitution: the importance of predictable and modifiable milestones of immune reconstitution to transplant outcomes

Published:2022-04 Issue:4 Volume:24 Page:385-392
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Bertaina Alice,Abraham Allistair^ORCID,Bonfim Carmem,Cohen Sandra,Purtill Duncan,Ruggeri Annalisa,Weiss Daniel,Wynn Robert,Boelens Jaap Jan,Prockop Susan^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference129 articles.

1. Immune reconstitution following hematopoietic stem cell transplantation using different stem cell sources;Elfeky;Expert Rev Clin Immunol,2019

2. Age-dependent incidence, time course, and consequences of thymic renewal in adults;Hakim;Journal of Clinical Investigation,2005

3. AGE, THYMOPOIESIS, AND CD4+ T-LYMPHOCYTE REGENERATION AFTER INTENSIVE CHEMOTHERAPY;Mackall;New England Journal of Medicine,1995

4. Strategies before, during, and after hematopoietic cell transplantation to improve T-cell immune reconstitution;de Koning;Blood,2016

5. Immune reconstitution following stem cell transplantation;van den Brink;Hematology Am Soc Hematol Educ Program,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune recovery and the role of recent thymic emigrated T lymphocytes after pediatric hematopoietic stem cell transplantation;Cytotherapy;2024-09

2. Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and Donors;Transplantation and Cellular Therapy;2024-08

3. Pre-graft vaccination or infection do not decrease COVID-19 infections in recipients of allogeneic stem cell transplantation vaccinated and/or protected by immunotherapy after transplant;Human Vaccines & Immunotherapeutics;2024-07-08

4. European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transplantation;Cytometry Part B: Clinical Cytometry;2024-06-28

5. The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases;American Journal of Hematology;2023-01-02